Assertio (formerly Depomed) is a specialty pharmaceutical company focused on developing and commercializing products to treat pain and other central nervous system conditions. It offers INDOCIN, a non-steroidal anti-inflammatory drug, and CAMBIA, a prescription medicine used to treat migraine attacks. In addition, the company provides ZIPSOR, a non-steroidal anti-inflammatory drug for the treatment of mild to moderate acute pain in adults, and SPRIX, a solution for the management of moderate to moderately severe pain that requires analgesia at the opioid level.
Type | Public | |
Founded | 1995 | |
HQ | Lake Forest, IL, US | Map |
Website | assertiotx.com | |
Employee Ratings | More |
USD | |
---|---|
Revenue (Q2, 2021) | 24.8m |
Market capitalization (26-Apr-2022) | 96.4m |
Closing stock price (26-Apr-2022) | 2.2 |
Cash (30-Jun-2021) | 54.4m |
EV | 121.0m |
USD | Q1, 2018 | Q2, 2018 | Q3, 2018 | Q1, 2019 | Q2, 2019 | Q3, 2019 | Q1, 2020 | Q2, 2020 | Q3, 2020 | Q1, 2021 | Q2, 2021 |
---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | 128.4m | 63.3m | 77.5m | 57.9m | 57.2m | 55.1m | 20.9m | 20.6m | 34.3m | 26.8m | 24.8m |
Cost of goods sold | 12.0m | 2.8m | 3.0m | 2.6m | 2.1m | 2.2m | 1.4m | 5.2m | 6.5m | 4.0m | |
Gross profit | 116.4m | 60.5m | 74.5m | 55.4m | 55.1m | 52.9m | 19.5m | 15.4m | 27.8m | 22.9m | |
Gross profit Margin, % | 91% | 96% | 96% | 96% | 96% | 96% | 93% | 75% | 81% | 85% |
USD | Q1, 2018 | Q2, 2018 | Q3, 2018 | Q1, 2019 | Q2, 2019 | Q3, 2019 | Q1, 2020 | Q2, 2020 | Q3, 2020 | Q1, 2021 | Q2, 2021 |
---|---|---|---|---|---|---|---|---|---|---|---|
Cash | 101.7m | 57.2m | 121.9m | 109.7m | 68.3m | 54.2m | 106.0m | 59.4m | 34.7m | 61.0m | 54.4m |
Accounts Receivable | 62.4m | 42.1m | 43.9m | 43.5m | 34.3m | 43.4m | 13.0m | 34.8m | 39.2m | 39.2m | 45.5m |
Prepaid Expenses | 23.8m | 22.7m | 57.3m | 25.7m | 26.2m | 23.5m | 10.7m | 15.9m | 17.1m | 14.9m | 12.8m |
Inventories | 5.4m | 5.0m | 4.3m | 3.1m | 3.0m | 3.3m | 518.0k | 25.4m | 13.5m | 8.9m | 6.6m |
USD | Q1, 2018 | Q2, 2018 | Q3, 2018 | Q1, 2019 | Q2, 2019 | Q3, 2019 | Q1, 2020 | Q2, 2020 | Q3, 2020 | Q1, 2021 | Q2, 2021 |
---|---|---|---|---|---|---|---|---|---|---|---|
Net Income | 33.8m | 12.8m | 61.0m | (14.3m) | (27.9m) | (24.6m) | 41.2m | 6.7m | (3.8m) | 4.5m | (9.6m) |
Depreciation and Amortization | 26.9m | 53.8m | 80.7m | 26.0m | 51.5m | 77.2m | 8.1m | 13.3m | 19.5m | 6.8m | 14.3m |
Inventories | 7.5m | 7.8m | 8.5m | (40.0k) | 195.0k | (213.0k) | (2.4m) | 512.0k | (792.0k) | 2.6m | 5.0m |
Accounts Payable | (33.5m) | (44.3m) | (28.1m) | (12.4m) | (14.9m) | 17.4m | (10.5m) | (13.3m) | (18.4m) | (16.7m) | (3.9m) |
USD | Q1, 2018 |
---|---|
Revenue/Employee | 755.3k |
Debt/Equity | 3.1 x |
Debt/Assets | 0.6 x |
Financial Leverage | 4.9 x |
Company Name | Date | Deal Size |
---|---|---|
Zyla Life Sciences | March 20, 2020 | |
Nautilus Neurosciences | December 17, 2013 | |
Alligator IP, LLC | ||
Assertio Distribution, LLC | ||
Assertio Management, LLC | ||
Assertio Therapeutics, Inc. | ||
Depo DR Sub, LLC | ||
Depo NF Sub, LLC | ||
Egalet Limited | ||
Zyla Life Sciences, Inc. |
Assertio revenue breakdown by business segment: 12.5% from Zipsor, 10.6% from Commercialization agreement revenue, 26.7% from CAMBIA, 10.4% from SPRIX, 29.8% from INDOCIN Products and 10.0% from Other
When was Assertio founded?
Assertio was founded in 1995.
Who are Assertio key executives?
Assertio's key executives are Dan A Peisert, Jeff Christensen and Sam Schlessinger.
How many employees does Assertio have?
Assertio has 27 employees.
What is Assertio revenue?
Latest Assertio annual revenue is $106.3 m.
What is Assertio revenue per employee?
Latest Assertio revenue per employee is $3.9 m.
Who are Assertio competitors?
Competitors of Assertio include JanOne, iNova Pharmaceuticals and Purdue Pharma.
Where is Assertio headquarters?
Assertio headquarters is located at Landmark of Lake Forest, 100 Saunders Rd Ste 300, Lake Forest.
Where are Assertio offices?
Assertio has an office in Lake Forest.
How many offices does Assertio have?
Assertio has 1 office.
Receive alerts for 300+ data fields across thousands of companies